Страна: Вірменія
мова: англійська
Джерело: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
citicoline (citicoline sodium)
Ferrer International
citicoline (citicoline sodium)
1000mg/4ml
solution for i/m and i/v injection
Prescription
SUMMARY PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT CERAXON 1000 mg solution for injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION CERAXON 1000 mg solution for injection is supplied in 4 ml glass ampoules. The active ingredient is Cticoline sodium 1045mg (equal to the 1000mg Citicoline) For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. CERAXON 1000 mg solution for injection: Clear and colourless water solution. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ischemic stroke, acute phase and its neurological sequelae (as a part of complex therapy) Rehabilitation period of ischemic and hemorrhagic stroke Traumatic Brain injury and its neurological sequelae, acute phase (as a part of complex therapy) and rehabilitation period Cognitive and behavioural impairment secondary to chronic vascular and degenerative cerebral disorders. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ADULTS: The recommended dose is from 500 to 2,000 mg/day, depending on the severity of the symptoms to be treated. It can be administered by intramuscular, slow intravenous route (from 3 to 5 minutes depending on the administered dose) or in intravenous drop perfusion (dripping speed: 40-60 drops per minute). THE DOSAGE RECOMMENDATIONS _The acute phase of Ischemic stroke and Traumatic Brain injury_ : 1000mg every 12 hours from the first day after diagnosis. , treatment duration of at least 6 weeks. It is possible a transition to the oral forms of Ceraxon 3-5 days after starting of treatment, if the swallowing function is not impaired. _Rehabilitation period of ischemic and hemorrhagic stroke, rehabilitation period of Traumatic Brain injury, _ _Cognitive and behavioural impairment secondary to chronic vascular and degenerative cerebral disorders: _ _ _ 500-2000mg daily. The dosage and duration of treatment depend on the severity of symptoms. The oral forms of Ceraxon can be used also See the instructions for preparation in section 6.6. ELDERLY: CERAXON does not need any s Прочитайте повний документ